SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001544227-20-000014
Filing Date
2020-05-08
Accepted
2020-05-08 07:36:34
Documents
49
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mlnd-20200331.htm   iXBRL 10-Q 1330506
2 EX-31.1 mlnd-20200331x10qexhib2.htm EX-31.1 11210
3 EX-31.2 mlnd-20200331x10qexhib1.htm EX-31.2 11179
4 EX-32.1 mlnd-20200331x10qexhib.htm EX-32.1 7165
  Complete submission text file 0001544227-20-000014.txt   4313784

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlnd-20200331.xsd EX-101.SCH 24808
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mlnd-20200331_cal.xml EX-101.CAL 52721
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mlnd-20200331_def.xml EX-101.DEF 111389
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlnd-20200331_lab.xml EX-101.LAB 387830
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlnd-20200331_pre.xml EX-101.PRE 224125
51 EXTRACTED XBRL INSTANCE DOCUMENT mlnd-20200331_htm.xml XML 535073
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35890 | Film No.: 20858684
SIC: 2834 Pharmaceutical Preparations